Alzheimer's disease & dementia

Researchers report promising new Alzheimer's drug

A new experimental treatment against Alzheimer's has proved to be promising and free of harmful side effects, researchers in the United States reported Wednesday.

Medications

Swiss pharma giant Novartis recalls drugs in US

Swiss pharmaceutical firm Novartis said Sunday it was recalling four different products sold over the counter in the United States over reports of a malfunction at one of its plants.

Medications

Argentina begins doling out free 'Viagra'

Argentina has begun distributing a free state-produced version of the erection-boosting drug Viagra for the first time, in a move intended to curb its misuse, health authorities announced Thursday.

Medications

S. Korea to approve Viagra generics

Three South Korean pharmaceutical firms will soon be allowed to produce generic versions of the anti-impotence drug Viagra despite a row over patents, officials said Wednesday.

Medications

New drug approved for lack of certain white blood cells

(HealthDay)—The U.S. Food and Drug Administration has approved the drug tbo-filgrastim to treat certain cancer patients undergoing chemotherapy who have a condition called severe neutropenia, the FDA said in a news release.

Medications

Pharma sector set for wave of mergers, acquisitions: study

The pharmaceuticals sector is facing an intensive period of mergers and acquisitions in the coming years, even if US firms Pfizer and Allergan recently failed to tie the knot, the corporate consultancy firm EY said Monday.

Alzheimer's disease & dementia

Major step toward an Alzheimer's vaccine

A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This ...

page 1 from 3